Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy

[1]  T. Newsome,et al.  TNF deficiency dysregulates inflammatory cytokine production leading to lung pathology and death during respiratory poxvirus infection , 2019, bioRxiv.

[2]  Wei Yue,et al.  Semi-quantitative Determination of Protein Expression using Immunohistochemistry Staining and Analysis: An Integrated Protocol. , 2019, Bio-protocol.

[3]  Si-jia Chen,et al.  Micheliolide Ameliorates Diabetic Kidney Disease by Inhibiting Mtdh-mediated Renal Inflammation in Type 2 Diabetic db/db Mice. , 2019, Pharmacological research.

[4]  L. Ruilope,et al.  Systemic Inflammation Precedes Microalbuminuria in Diabetes , 2019, Kidney international reports.

[5]  Hao Wu,et al.  Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease. , 2018, Clinical science.

[6]  Z. Dong,et al.  Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease , 2018, EBioMedicine.

[7]  L. Tang,et al.  miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression , 2018, Front. Pharmacol..

[8]  R. Nitschke,et al.  Cilia‐localized LKB1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney , 2018, The EMBO journal.

[9]  Xiaodong Cheng,et al.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development. , 2018, Physiological reviews.

[10]  M. Eldosoky,et al.  Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats. , 2018, Chemico-biological interactions.

[11]  K. Zen,et al.  PDE/cAMP/Epac/C/EBP-β Signaling Cascade Regulates Mitochondria Biogenesis of Tubular Epithelial Cells in Renal Fibrosis. , 2017, Antioxidants & redox signaling.

[12]  E. Feigerlová,et al.  IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives. , 2017, Cytokine & growth factor reviews.

[13]  R. Gilbert.  Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease , 2017, Diabetes.

[14]  Lin Sun,et al.  The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1 , 2016, Redox biology.

[15]  S. Okumura,et al.  Epac activation inhibits IL-6-induced cardiac myocyte dysfunction , 2016, The Journal of Physiological Sciences.

[16]  U. Klueh,et al.  Impact of CCL2 and CCR2 chemokine/receptor deficiencies on macrophage recruitment and continuous glucose monitoring in vivo. , 2016, Biosensors & bioelectronics.

[17]  S. Seino,et al.  Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance , 2016, International Journal of Obesity.

[18]  K. Zen,et al.  Broad Infiltration of Macrophages Leads to a Proinflammatory State in Streptozotocin-Induced Hyperglycemic Mice , 2016, The Journal of Immunology.

[19]  J. Coresh,et al.  Trends in Chronic Kidney Disease in China. , 2016, The New England journal of medicine.

[20]  T. Rabelink,et al.  Macrophages in diabetic nephropathy in patients with type 2 diabetes , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  F. Lezoualc’h,et al.  Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease. , 2016, Circulation research.

[22]  Y. Kanwar,et al.  Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. , 2015, Journal of the American Society of Nephrology : JASN.

[23]  J. Vacher,et al.  Macrophage-derived Tumor Necrosis Factor-α mediates diabetic renal injury , 2015, Kidney international.

[24]  T. Palmer,et al.  The future of EPAC-targeted therapies: agonism versus antagonism , 2015, Trends in pharmacological sciences.

[25]  D. Bonthron,et al.  Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[26]  A. Harvey,et al.  Cyclic AMP and the regeneration of retinal ganglion cell axons. , 2014, The international journal of biochemistry & cell biology.

[27]  B. van de Water,et al.  Epac-Rap signaling reduces oxidative stress in the tubular epithelium. , 2014, Journal of the American Society of Nephrology : JASN.

[28]  P. Xie,et al.  Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology. , 2014, American journal of physiology. Renal physiology.

[29]  T. Cooper,et al.  Macrophages directly mediate diabetic renal injury. , 2013, American journal of physiology. Renal physiology.

[30]  J. Bos,et al.  Exchange protein activated by cAMP 1 (Epac1)‐deficient mice develop β‐cell dysfunction and metabolic syndrome , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  S. Døskeland,et al.  Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets. , 2013, Biochemical and biophysical research communications.

[32]  J. Scholey,et al.  Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways. , 2013, American journal of physiology. Renal physiology.

[33]  G. Tesch,et al.  Inflammation in Diabetic Nephropathy , 2012, Mediators of inflammation.

[34]  F. Verbeek,et al.  cAMP signalling protects proximal tubular epithelial cells from cisplatin‐induced apoptosis via activation of Epac , 2012, British journal of pharmacology.

[35]  B. van de Water,et al.  Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure. , 2011, Journal of the American Society of Nephrology : JASN.

[36]  A. Sanz,et al.  Suppressors of cytokine signaling abrogate diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[37]  G. Tesch.  Macrophages and diabetic nephropathy. , 2010, Seminars in nephrology.

[38]  O. Chepurny,et al.  PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans. , 2010, American journal of physiology. Endocrinology and metabolism.

[39]  O. Chepurny,et al.  Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2’-O-Me-cAMP-AM , 2009, Islets.

[40]  D. Levy,et al.  Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy. , 2009, Kidney international.

[41]  Fu-you Liu,et al.  C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy. , 2009, Journal of the American Society of Nephrology : JASN.

[42]  F. Lezoualc’h,et al.  Functional characterization of the cAMP-binding proteins Epac in cardiac myocytes , 2009, Pharmacological reports : PR.

[43]  T. Palmer,et al.  Identification of CCAAT/Enhancer-binding Proteins as Exchange Protein Activated by cAMP-activated Transcription Factors That Mediate the Induction of the SOCS-3 Gene* , 2008, Journal of Biological Chemistry.

[44]  J. Guh,et al.  Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells. , 2007, American journal of physiology. Renal physiology.

[45]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[46]  T. Kodama,et al.  Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation , 2007, Diabetes.

[47]  T. Palmer,et al.  Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells , 2006, Molecular and Cellular Biology.

[48]  M. Marrero,et al.  Role of the JAK/STAT signaling pathway in diabetic nephropathy. , 2006, American journal of physiology. Renal physiology.

[49]  D. Adu,et al.  The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. , 2006, Kidney international.

[50]  R. Rabkin,et al.  Suppressors of cytokine signaling in health and disease , 2005, Pediatric Nephrology.

[51]  J. Egido,et al.  NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  Xiaodan Wang,et al.  Inhibition of the JAK/STAT Signaling Pathway Prevents the High Glucose-Induced Increase in TGF-β and Fibronectin Synthesis in Mesangial Cells , 2002 .

[53]  A. Wittinghofer,et al.  Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs* , 2000, The Journal of Biological Chemistry.

[54]  A. Wittinghofer,et al.  Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.

[55]  Robert V Farese,et al.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.

[56]  T. Palmer,et al.  Exchange protein directly activated by cyclic AMP-1-regulated recruitment of CCAAT/enhancer-binding proteins to the suppressor of cytokine signaling-3 promoter. , 2012, Methods in molecular biology.

[57]  R. Atkins,et al.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. , 2006, Kidney international.